Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile.
作者信息
Percival Mary-Elizabeth M, Medeiros Bruno C, Tian Lu, Robeson Sarah, Laport Ginna G, Johnston Laura J, Shizuru Judith A, Miklos David B, Arai Sally, Weng Wen-Kai, Negrin Robert S, Lowsky Robert
机构信息
Division of Hematology, Stanford University School of Medicine, Stanford, CA.
Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA.
出版信息
Bone Marrow Transplant. 2015 Jul;50(7):1004-1006. doi: 10.1038/bmt.2015.62. Epub 2015 Apr 20.
Abstract
摘要
相似文献
1
Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile.
Bone Marrow Transplant. 2015 Jul;50(7):1004-1006. doi: 10.1038/bmt.2015.62. Epub 2015 Apr 20.
2
Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Haematologica. 2016 Feb;101(2):248-55. doi: 10.3324/haematol.2015.132654. Epub 2015 Nov 20.
3
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT).
Am J Hematol. 2015 Aug;90(8):719-24. doi: 10.1002/ajh.24069.
4
Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.
Haematologica. 2015 Jul;100(7):e254-6. doi: 10.3324/haematol.2014.118570. Epub 2015 Mar 20.
5
Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual disease.
Best Pract Res Clin Haematol. 2015 Jun-Sep;28(2-3):133-40. doi: 10.1016/j.beha.2015.10.010. Epub 2015 Oct 22.
6
Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.
Eur J Haematol. 2014 Feb;92(2):102-10. doi: 10.1111/ejh.12216. Epub 2013 Nov 21.
7
Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ann Hematol. 2016 Jan;95(2):301-10. doi: 10.1007/s00277-015-2540-7. Epub 2015 Nov 4.
8
[Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia--recent progress].
Nihon Rinsho. 2009 Oct;67(10):1944-50.
9
Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
Biol Blood Marrow Transplant. 2014 Jan;20(1):80-8. doi: 10.1016/j.bbmt.2013.10.015. Epub 2013 Oct 20.
10
Allogeneic hematopoietic cell transplantation may alleviate the negative prognostic impact of monosomal and complex karyotypes on patients with acute myeloid leukemia.
Biol Blood Marrow Transplant. 2014 May;20(5):690-5. doi: 10.1016/j.bbmt.2014.01.027. Epub 2014 Jan 31.
本文引用的文献
1
European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Blood Cancer J. 2014 May 30;4(5):e216. doi: 10.1038/bcj.2014.35.
2
Indications for allogeneic hematopoietic cell transplantation for acute myeloid leukemia in the genomic era.
Am Soc Clin Oncol Educ Book. 2014:e327-33. doi: 10.14694/EdBook_AM.2014.34.e327.
3
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
J Clin Oncol. 2012 Dec 20;30(36):4515-23. doi: 10.1200/JCO.2012.43.4738. Epub 2012 Sep 17.
4
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
N Engl J Med. 2012 Mar 22;366(12):1079-89. doi: 10.1056/NEJMoa1112304. Epub 2012 Mar 14.
5
Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.
J Clin Oncol. 2012 Mar 1;30(7):735-41. doi: 10.1200/JCO.2011.36.9868. Epub 2012 Jan 30.
6
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.
J Clin Oncol. 2011 Jul 10;29(20):2758-65. doi: 10.1200/JCO.2010.32.8500. Epub 2011 May 31.
7
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY.
Bone Marrow Transplant. 2011 Feb;46(2):192-9. doi: 10.1038/bmt.2010.114. Epub 2010 May 24.
8
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Blood. 2010 Jan 21;115(3):453-74. doi: 10.1182/blood-2009-07-235358. Epub 2009 Oct 30.
9
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies.
Blood. 2008 Jul 15;112(2):415-25. doi: 10.1182/blood-2007-08-104745. Epub 2008 May 1.
10
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
N Engl J Med. 2008 May 1;358(18):1909-18. doi: 10.1056/NEJMoa074306.
Zotero 插件